The US laws authorise the drug and health watchdog to assess and collect user fees for certain applications and supplements for human generic drug products
The fees for facility inspection of foreign companies have been reduced
HSBC maintained "overweight" rating on Indian equities, saying "fundamentals are strong".
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances